2011
DOI: 10.1016/j.jacc.2011.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Guiding Left Ventricular Lead Positioning and Refining Ability to Predict Response and Nonresponse to Cardiac Resynchronization Therapy Using dP/dtmax

Abstract: Ability to predict response to cardiac resynchronization therapy (CRT) has been one of the challenges in the treatment of heart failure (HF). Although CRT has been associated with significant clinical improvement in large clinical trials (1-3), approximately 30% of the patients do not experience clinical improvement (4). Several factors of CRT nonresponse have been implicated, such as inappropriate left ventricular (LV) lead positioning, the extent and location of See page 1128 scar tissue, lack of LV mechanic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 19 publications
0
3
1
Order By: Relevance
“…They comment that our results fit with physiological concepts regarding cardiac resynchronization therapy but are not supported by their findings that baseline rather than change in (the maximum rate of LV pressure rise LVdP/dt max ) predicted survival (2).…”
Section: Replycontrasting
confidence: 84%
See 2 more Smart Citations
“…They comment that our results fit with physiological concepts regarding cardiac resynchronization therapy but are not supported by their findings that baseline rather than change in (the maximum rate of LV pressure rise LVdP/dt max ) predicted survival (2).…”
Section: Replycontrasting
confidence: 84%
“…We note the findings of Bogaard et al (2) and would like to highlight several important differences between studies. Their patient population was different and predominantly ischemic: 56% versus 36% in our study.…”
Section: Replymentioning
confidence: 68%
See 1 more Smart Citation
“…It is possible that the FFR-induced increment in inotropy in our study (+ 3 ± 0.9% points absolute increment in ejection fraction between CRT vs. AAI–VVI pacing modes at maximum heart rate achieved [data not shown]), which was less than what we obtain with dobutamine infusion (> 5 points absolute increment in the LODO-CRT trial [3]), was inadequate for evoking any obvious beneficial effect during the follow-up. In any case, it remains unclear whether a response to early surrogate testing would identify the chronic responders to CRT with respect to hard clinical end points [25]. This reasoning is in line with another report that described how the acute improvement in dP/dt max was not correlated to the clinical outcome, although dP/dt max , measured at baseline and during CRT, was a predictor of 1-year survival free from mortality, heart transplantation, or LV assist device implantation [26].…”
Section: Discussionmentioning
confidence: 99%